Santen Pharmaceutical's Chongqing subsidiary has reportedly begun procedures to prepare for a bankruptcy filing, with attention focused on the potential impact.
Santen Pharmaceutical's Chongqing subsidiary has reportedly begun procedures to prepare for a bankruptcy filing. Attention is expected to focus on future developments concerning the group's business operations and asset position.
The future course of the subsidiary's legal restructuring, the impact on business partners and the treatment of employees could become focal points, but the article provides no specific figures or timing at this stage.